Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To investigate factors, including cognitive and brain reserve, which may independently predict prevalent and incident dementia of the Alzheimer type (DAT) and to determine whether inclusion of identified factors increases the predictive accuracy of the CSF biomarkers Aβ42, tau, ptau181, tau/Aβ42, and ptau181/Aβ42.
Methods: Logistic regression identified variables that predicted prevalent DAT when considered together with each CSF biomarker in a cross-sectional sample of 201 participants with normal cognition and 46 with DAT. The area under the receiver operating characteristic curve (AUC) from the resulting model was compared with the AUC generated using the biomarker alone. In a second sample with normal cognition at baseline and longitudinal data available (n = 213), Cox proportional hazards models identified variables that predicted incident DAT together with each biomarker, and the models' concordance probability estimate (CPE), which was compared to the CPE generated using the biomarker alone.
Results: APOE genotype including an ε4 allele, male gender, and smaller normalized whole brain volumes (nWBV) were cross-sectionally associated with DAT when considered together with every biomarker. In the longitudinal sample (mean follow-up = 3.2 years), 14 participants (6.6%) developed DAT. Older age predicted a faster time to DAT in every model, and greater education predicted a slower time in 4 of 5 models. Inclusion of ancillary variables resulted in better cross-sectional prediction of DAT for all biomarkers (p < 0.0021), and better longitudinal prediction for 4 of 5 biomarkers (p < 0.0022).
Conclusions: The predictive accuracy of CSF biomarkers is improved by including age, education, and nWBV in analyses.
Footnotes
Study funding: Supported by the NIH (NINDS P30 NS057105, NIA P50 AG005681, P01 AG003991, and P01 AG026276); the NCRR (KL2RR024994 and 1UL1RR024992); and the Charles F. and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Center.
Editorial, page 496
Supplemental data at www.neurology.org
-
- AD
- Alzheimer disease
- AUC
- area under the receiver operating characteristic curve
- CDR
- Clinical Dementia Rating
- CPE
- concordance probability estimate
- CS
- collateral source
- DAT
- dementia of the Alzheimer type
- GDS
- Geriatric Depression Scale
- LP
- lumbar puncture
- MMSE
- Mini Mental-State Examination
- nWBV
- normalized whole brain volume
- ROC
- receiver operating characteristic
- Received May 14, 2010.
- Accepted September 20, 2010.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Alzheimer disease identification using amyloid imaging and reserve variablesProof of conceptC.M. Roe, M.A. Mintun, N. Ghoshal et al.Neurology, July 05, 2010 -
Articles
Normative estimates of cross-sectional and longitudinal brain volume decline in aging and ADA. F. Fotenos, A. Z. Snyder, L. E. Girton et al.Neurology, March 21, 2005 -
Articles
CSF biomarkers of Alzheimer disease in HIV-associated neurologic diseaseD. B. Clifford, A. M. Fagan, D. M. Holtzman et al.Neurology, November 11, 2009 -
Articles
[11C]PIB in a nondemented populationPotential antecedent marker of Alzheimer diseaseM. A. Mintun, G. N. LaRossa, Y. I. Sheline et al.Neurology, August 07, 2006